Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Shengjing Lung Cancer Cohort: Risk Factors for Disease Development and Progression

Official title: The Shengjing Lung Cancer Cohort (SJ-LCC) Study

Run by Shengjing Hospital · NCT07779005 · Data updated 2026-11-12

This study tests how lifestyle and diet factors influence outcomes for adults with newly diagnosed lung cancer to see if these factors are linked to prognosis.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment1500 (estimated)
SponsorShengjing Hospital
Academic / other
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedFebruary 1, 2019
Main results expectedDecember 30, 2024
Study endsDecember 31, 2029
Registry record updatedAugust 21, 2026
Trial IDNCT07779005 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with newly confirmed lung cancer diagnosed within the last 6 months and able to comply with questionnaires and sample collection.

Probably not a fit

Patients who are outside the age range, have non-primary or non-newly diagnosed lung cancer, or cannot participate fully may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study follows people with newly diagnosed lung cancer to explore how smoking, alcohol use, diet, and emotional well-being relate to disease progression and prognosis. The researchers collect dietary information with a validated questionnaire and perform multi-omics analyses on tumor tissue, blood, urine, and stool. By linking exposure data with clinical follow-up, the project aims to identify prognostic factors and biological pathways that may affect long-term outcomes. The study is conducted at Shengjing Hospital in Shenyang, China, with participants aged 18 to 75 who meet eligibility criteria and provide consent.

Why it matters

Potential benefit: If successful, results could improve understanding of how lifestyle and biological factors influence lung cancer progression and patient prognosis.

How similar studies have gone: Previous observational efforts using cohorts and multi-omics have provided signals about prognostic factors, though this exact combination in lung cancer is still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged between 18 and 75 years;
2. Patients with newly, pathologically confirmed lung cancer;
3. Patients diagnosed within the preceding 6 months (time since confirmed diagnosis \< 6 months).

Exclusion Criteria:

1. Individuals aged outside the range of 18-75 years, or those in poor general physical condition who are unable to cooperate with the questionnaire survey;
2. Patients with non-primary lung cancer, non-newly diagnosed lung cancer, or those unable to provide definitive pathological confirmation;
3. Individuals with severe depression, pregnant women, or those diagnosed with severe cardiovascular/cerebrovascular diseases or severe metabolic dysfunctions affecting the liver, kidneys, or other major organs;
4. Individuals unwilling to participate in the study.

Where it's running

  • Shengjing Hospital affiliated to China Medical University
    Shenyang, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.